Literature DB >> 30099985

Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.

Saeko Osawa1, Naoto Katakami2, Ihoko Sato3, Hiroyo Ninomiya3, Kazuo Omori3, Yuichi Yamamoto4, Mitsuyoshi Takahara5, Kazuyuki Miyashita3, Fumie Sakamoto3, Dan Kawamori6, Takaaki Matsuoka3, Iichiro Shimomura3.   

Abstract

AIMS: Tissue accumulatedadvanced glycation end products (AGEs) can be evaluated non-invasively by an autofluorescence reader as skin autofluorescence (skin AF)·The present study investigated whether skin AF is associated with diabetic micro- and macroangiopathies in Japanese patients with type 2 diabetes mellitus (T2DM).
METHODS: Skin AF was measured in 193 enrolled Japanese patients with T2DM and 24 enrolled healthy non-diabetic subjects by using the AGE reader®. Diabetic micro- and macroangiopathies were evaluated in the T2DM patients.
RESULTS: Skin AF was significantly increased in patients with T2DM than in age- and sex-matched non-diabetic controls (2.35 ± 0.51 [mean ± SD] and 1.91 ± 0.29, respectively, p = 0.001). In subjects with T2DM, skin AF was associated with age, pack-years of smoking, and eGFR (estimated glomerular filtration rate) independently. Skin AF was significantly increased in patients with diabetic retinopathy, neuropathy, nephropathy, and macroangiopathy than in those without them, and significantly associated with the number of diabetic complications. Moreover, skin AF was an independent predictor for diabetic retinopathy, neuropathy, and nephropathy but not macroangiopathy, after adjusting for major traditional risk factors.
CONCLUSIONS: Skin AF is an independent predictor for diabetic retinopathy, neuropathy and nephropathy in Japanese patients with T2DM.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced glycation end products (AGEs); Cross-sectional study; Diabetic complications; Skin autofluorescence; Type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 30099985     DOI: 10.1016/j.jdiacomp.2018.06.009

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  9 in total

1.  Within- and Between-Body-Site Agreement of Skin Autofluorescence Measurements in People With and Without Diabetes-Related Foot Disease.

Authors:  Malindu E Fernando; Robert G Crowther; Peter A Lazzarini; Kunwarjit S Sangla; Scott Wearing; Petra Buttner; Jonathan Golledge
Journal:  J Diabetes Sci Technol       Date:  2019-06-16

2.  Skin accumulation of advanced glycation end products and cardiovascular risk in Korean patients with type 2 diabetes mellitus.

Authors:  Lee-Seoul Choi; Kainat Ahmed; Young-Seol Kim; Jung-Eun Yim
Journal:  Heliyon       Date:  2022-06-02

Review 3.  Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes.

Authors:  Alejandra Planas; Olga Simó-Servat; Cristina Hernández; Rafael Simó
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

4.  Measures of lung function and their relationship with advanced glycation end-products.

Authors:  Suneela Zaigham; Margaretha Persson; Amra Jujic; Sophia Frantz; Yan Borné; Andrei Malinovschi; Per Wollmer; Gunnar Engström
Journal:  ERJ Open Res       Date:  2020-06-01

5.  Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis.

Authors:  Mahboobeh Sadat Hosseini; Zahra Razavi; Amir Houshang Ehsani; Alireza Firooz; Siamack Afazeli
Journal:  EClinicalMedicine       Date:  2021-11-16

6.  A Prospective Analysis of Skin and Fingertip Advanced Glycation End-Product Devices in Healthy Volunteers.

Authors:  Dominik Adl Amini; Manuel Moser; Erika Chiapparelli; Lisa Oezel; Jiaqi Zhu; Ichiro Okano; Jennifer Shue; Andrew A Sama; Frank P Cammisa; Federico P Girardi; Alexander P Hughes
Journal:  J Clin Med       Date:  2022-08-12       Impact factor: 4.964

7.  Are Advanced Glycation End Products in Skin Associated with Vascular Dysfunction Markers? A Meta-Analysis.

Authors:  Alicia Saz-Lara; Celia Álvarez-Bueno; Vicente Martínez-Vizcaíno; Blanca Notario-Pacheco; Irene Sequí-Dominguez; Iván Cavero-Redondo
Journal:  Int J Environ Res Public Health       Date:  2020-09-22       Impact factor: 3.390

Review 8.  Skin AGEs and diabetic neuropathy.

Authors:  Stella Papachristou; Kalliopi Pafili; Nikolaos Papanas
Journal:  BMC Endocr Disord       Date:  2021-02-23       Impact factor: 2.763

9.  Skin Advanced Glycation End Products among Subjects with Type 2 Diabetes Mellitus with or without Distal Sensorimotor Polyneuropathy.

Authors:  Stella Papachristou; Kalliopi Pafili; Grigorios Trypsianis; Dimitrios Papazoglou; Konstantinos Vadikolias; Nikolaos Papanas
Journal:  J Diabetes Res       Date:  2021-11-28       Impact factor: 4.011

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.